LILRB4 STAR-T Cells in the Treatment of R/R AML/CMML
Clinical trial NCT05548088 · COMPLETED
Trial details
- NCT number
- NCT05548088
- Sponsor
- Peking University People's Hospital
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-25
- Primary completion
- 2024-08-03
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.